Home/Filings/4/0000950170-24-094139
4//SEC Filing

CARLSON MARILYN R. 4

Accession 0000950170-24-094139

CIK 0001403708other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:51 PM ET

Size

5.5 KB

Accession

0000950170-24-094139

Insider Transaction Report

Form 4
Period: 2024-08-07
CARLSON MARILYN R.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-07+17,29117,291 total
    Exercise: $5.27Exp: 2034-08-06Common Stock (17,291 underlying)
Footnotes (1)
  • [F1]1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1
  • filerCIK 0001592848

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:51 PM ET
Size
5.5 KB